Pantoprazol Apharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Apharma, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease and helps protect the stomach lining in patients at risk of ulcers. GNH USA supplies Pantoprazol Apharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Pantoprazol Apharma is a proton pump inhibitor that reduces gastric acid secretion in several acid‑related conditions. - Erosive esophagitis: promotes healing of damaged esophageal tissue. - Gastro‑oesophageal reflux disease (GERD): relieves heartburn and prevents further mucosal injury. - Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Pantoprazol Apharma may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache  - Diarr‑di  - Nausea  - Abdominal  y - Flat  -  Serious or Rare : -  t  t  t  t  t

Pantoprazum  t     t.

   \

   t \n  ewline